BRAVOS Afterloader Family: BRAVOS Afterloader System, Transfer Guide Tubes and Length Assessment Device
System, Applicator, Radionuclide, Remote-Controlled. 510(k) K221797, from Varian Medical Systems, Inc. (Palo Alto, CA). Product code JAQ, class 2.
As of Nov 20, 2026, K221797 is an FDA 510(k) held by Varian Medical Systems, Inc., substantially equivalent on Sep 14, 2022 after 85 days, with no recalls tied to it in FDA's recall database.
- Review time: 85 days
- Recalls: 0
The Bravos Afterloader System is indicated for use in the treatment of both benign and malignant disease or other conditions, for both curative and palliative intent, in the delivery of remote-controlled High Dose Rate (HDR) brachytherapy. The Transfer Guide Tubes are intended to connect between the Bravos Remote Afterloader system and its range of applicators.
- BRAVOS Afterloader System, Transfer Guide Tubes, Length Assessment DeviceK191580 · Varian Medical Systems, Inc. · Jul 8, 2019
- LumenCare AzureK262383 · Nucletron B.V. · Jul 24, 2026
- MAASTRO Rectal Applicator SetK252717 · Varian Medical Systems · May 20, 2026
- Rectal ApplicatorK251037 · Nucletron B.V. · Dec 19, 2025
- Guided Aarhus Applicator SetK252884 · Varian Medical Systems · Nov 19, 2025
- CT/ MR Tandem and Ovoid SetK250299 · Varian Medical Systems, Inc. · May 9, 2025
- Intracavitary/Interstitial SystemK250289 · Varian Medical Systems · Apr 25, 2025
- Titanium Flexible Geometry FSD Applicator Set (GM11013400)K243939 · Varian Medical Systems, Inc. · Mar 3, 2025
- Mould Probe MR SafeK241764 · Varian Medical Systems, Inc. · Jan 10, 2025
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jun 21, 2022
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5700
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files